Financial Institutions, Inc. Announces Acquisition of Robshaw & Julian Associates, Inc.
Aug 31, 2017 20:05 pm UTC| Business
– Williamsville, New York Investment Advisor Acquired by Courier Capital, LLC Subsidiary – Increases Assets Under Management to Approximately $1.6 Billion WARSAW, N.Y., Aug. 31, 2017 -- Financial...
BeiGene Announces Closing of Global Strategic Oncology Collaboration with Celgene Corporation
Aug 31, 2017 20:05 pm UTC| Business
CAMBRIDGE, Mass. and BEIJING, China, Aug. 31, 2017 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of...
Avista Makes Annual Price Adjustment Requests in Washington
Aug 31, 2017 20:05 pm UTC| Business
SPOKANE, Wash., Aug. 31, 2017 -- Avista (NYSE:AVA) has made several annual rate adjustment filings with the Washington Utilities and Transportation Commission (UTC or Commission) that would, if approved, result in a...
Snyder’s-Lance to Present at Barclays Global Consumer Staples Conference
Aug 31, 2017 20:05 pm UTC| Business
CHARLOTTE, N.C., Aug. 31, 2017 -- Snyder’s-Lance, Inc. (Nasdaq:LNCE), today announced Brian Driscoll, President and Chief Executive Officer, and Alexander Pease, Executive Vice President and Chief Financial Officer,...
Oxford Announces Fiscal 2017 Second Quarter Results
Aug 31, 2017 20:05 pm UTC| Business
-- Strong Performance at Tommy Bahama Continues----Lilly Pulitzer Acquires Licensed Signature Stores in Key Northeast Markets---- Reports Second Quarter GAAP EPS of $1.36; Adjusted EPS of $1.44 at Top of Guidance Range----...
Aug 31, 2017 20:05 pm UTC| Business
SAN DIEGO, Aug. 31, 2017 -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced the appointment...
TRACON Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference
Aug 31, 2017 20:05 pm UTC| Business
SAN DIEGO, Aug. 31, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...